What Neon Laboratories does

Neon Laboratories generates revenue through one-time B2B pharmaceutical product sales, distributed via a direct enterprise field sales force that reaches 40,000 anaesthesiologists and engages hospital procurement teams across India, and through channel/distributor partnerships exporting to 70+ countries across Latin America, Africa, the Middle East, Europe, Southeast Asia, CIS, and SAARC, with 461 products registered worldwide. The go-to-motion emphasizes a complete-basket proposition — first Indian company with the entire critical care basket under one roof, and the widest anaesthesia range in India — supported by economical oncology pricing aimed at affordability. Customers are highly fragmented across hospitals, ICUs, ICCUs, trauma centers, and individual specialists across nine therapeutic segments; pricing is not publicly disclosed and is negotiated through B2B channels to healthcare providers.

Name

Neon Laboratories

Legal name

Neon Laboratories Limited

Website

https://neongroup.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

101–250 employees

Short description

Neon Laboratories is a privately held Indian specialty pharmaceutical manufacturer producing 500+ parenteral and oral formulations across nine therapeutic segments, including anaesthesia, critical care, oncology, and medical devices, for hospitals and specialists in 70+ countries.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)

akta.pro secondary industries

Sterile Injectable Generics (HLAIABAC), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Specialty pharmaceutical manufacturing
• Parenteral formulations
• Anaesthesia medicines
• Critical care injectables
• Oncology pharmaceuticals

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Revenue model

1. Pharmaceutical Product Sales: NEON manufactures and sells specialty and generic pharmaceutical products across 9 therapeutic segments including Anaesthesiology, Critical Care, Pain Management, Gynaecology, Ophthalmology, Orthopaedic, Oncology, Dermatology, and Medical Devices. Products are sold under brand names and exported to 70+ countries.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Neon Laboratories manufactures and sells specialty and generic pharmaceutical formulations including parenterals (liquid injections, lyophilized injections, dry powder injections) and oral solid dosage forms. Its portfolio of 500+ products spans nine therapeutic segments — Anaesthesiology, Critical Care, Pain Management, Gynaecology, Ophthalmology, Orthopaedic, Oncology, Dermatology, and Medical Devices — sold under proprietary brand names in India and exported to 70+ countries.

Product overview

Neon Laboratories is an Indian pharmaceutical company specializing in parenteral and oral formulations with over 500 products across 9 therapeutic segments. The company's core portfolio centers on anesthesia and critical care medicines, with flagship products including Propofol (MCT-ROF, NEOROF), Bupivacaine (ANAWIN, LEVO-ANAWIN), Ropivacaine (ROPIN HEAVY - patented), and Lignocaine (LOX). Beyond anesthesia, Neon offers comprehensive critical care products including cardiovascular agents (NORAD, DOTAMIN, DOMIN), antibiotics (VANKING, EUPEN, LINETIC), and neurological drugs. The company has expanded into oncology (with chemotherapeutic agents like TAXELEON Paclitaxel, METODOX Doxorubicin, and targeted therapies like CHEMOTINIB Imatinib), pain management (NEOMOL Paracetamol, BUPRIGESIC Buprenorphine), gynaecology (GESTEROL Progesterone, fertility hormones NEO FSH/HCG/HMG), ophthalmology (ILIFE artificial tears, MOXPLORE antibiotics), orthopaedics (VITANEO D3, corticosteroids), and dermatology (PRILOX topical anesthetic - first introduced in India). The HOSPRO medical device division offers infection control products (Foley catheters, CVCs), anesthesia devices (endotracheal tubes, ventilator circuits), infusion therapy equipment, and respiratory masks. Neon exports to 70+ countries with 461 products registered worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• HOSPRO: Medical device division specializing in infection control, anesthesia, respiratory & critical care, infusion therapy, advanced wound management and surgical technologies.
• Neon Foundation
• ROPIN
• ANAWIN
• LOX
• Cis-Artacil
• PRILOX

Products and services

• Anaesthesiology Product Range Comprehensive anaesthesia medicines including Propofol injections (MCT-ROF, NEOROF), Bupivacaine (ANAWIN), Levobupivacaine (LEVO-ANAWIN), patented Ropivacaine (ROPIN HEAVY), Lignocaine (LOX), neuromuscular blockers (ARTACIL, CIS-ARTACIL, NEOVEC, ROCUNIUM), inhalation anaesthetics (HYPNOTHANE, SEVURA, SOSRANE), and sedatives (DEXTOMID, MEZOLAM), targeted at anaesthesiologists and surgical settings.
• Critical Care Product Range Complete basket of critical care injectables for ICUs, ICCUs, and trauma centers including vasopressors (NORAD, DOTAMIN, DOMIN), antibiotics (VANKING Vancomycin, EUPEN Meropenem, LINETIC Linezolid), and neurological drugs (EPICETAM Levetiracetam, NETICOL Citicoline) for life-threatening emergencies.
• Oncology Product Range Affordable chemotherapy products including anthracyclines (METODOX Doxorubicin), taxanes (TAXELEON Paclitaxel, DOCAX Docetaxel), platinum agents (CIZCAN Cisplatin, OXYREA Oxaliplatin), antimetabolites (GEMCHEM Gemcitabine), targeted therapies (CHEMOTINIB Imatinib), and supportive care biologics (ERYTRUST Erythropoietin, FILNEON Filgrastim) for cancer treatment.
• Pain Management Product Range Analgesics and pain management formulations including NEOMOL (Paracetamol injection, IV infusion, suppositories), BUPREGESIC (Buprenorphine injection and transdermal patches), SUPRIDOL (Tramadol), and JUSTIN (Diclofenac) for pre-, intra-, and post-operative pain management.

Quantifiable outcome

• Serving pharmaceutical industry for over 4 decades with complete range of anaesthesia and allied products
• +2 more outcomes

Segments6 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators6 records

Recent moves15 records

Expansion highlights6 records

Direct peers

• Claris Injectables (formerly Claris Lifesciences): Mumbai-based sterile injectable specialist supplying anaesthesia, critical care and anti-infectives to India and over 75 countries. Direct overlap with Neon on small-volume parenterals, lyophilized injectables and global export channels through partners.
• Akums Drugs & Pharmaceuticals: One of India's largest CDMOs with deep sterile injectable, lyophilized and small-volume parenteral capabilities for domestic and export markets. Comparable manufacturing platform and therapeutic breadth across injectables.
• Celon Laboratories: Indian specialty pharma focused on oncology injectables and critical care, with lyophilized manufacturing for doxorubicin, paclitaxel and supportive care. Comparable therapy mix (chemotherapy plus ICU) and India-led export model.
• Themis Medicare: Indian pharma with active presence in critical care injectables, anaesthesia and institutional/hospital channels. Comparable India-focused GTM and parenteral manufacturing footprint.
• Bharat Serums and Vaccines: Indian specialty injectable and biologic manufacturer with a strong focus on women's health, critical care, and anaesthesia products. Closely comparable product mix, therapy segments (including infertility hormones) and India-centric plus export distribution model.

Broad incumbents

• Cipla: One of India's largest pharma companies with broad institutional, respiratory, oncology and critical-care injectable lines; major exporter to emerging markets comparable to Neon's Africa/CIS/Southeast Asia channels.
• Fresenius Kabi: Global leader in sterile injectable generics and infusion/medical device portfolio, with strong anaesthesia, oncology and critical-care lines. Comparable portfolio across the same therapy areas where Neon competes, but at vastly larger global scale.
• B. Braun Melsungen: German medical device and pharmaceutical company with a large anaesthesia/regional anaesthesia portfolio plus infusion, IV and critical-care consumables that overlap with Neon's HOSPRO devices and anaesthesia drugs.
• Dr. Reddy's Laboratories: Indian multinational with deep sterile injectable, oncology and biosimilar franchises exported globally. Comparable international regulatory reach and parenteral manufacturing footprint, though materially larger scale.

Regional players

• Lincoln Pharmaceuticals: Indian pharma with focus on injectables, gynaecology and critical care segments, exporting primarily to Africa, Asia and Latin America. Comparable mid-tier Indian specialty injectable exporter profile, though with smaller scale and less anaesthesia depth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neon Laboratories